InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: juslin post# 278243

Friday, 06/05/2020 9:31:07 PM

Friday, June 05, 2020 9:31:07 PM

Post# of 424701
juslin...

"So since there was a statistical error in the original paper referenced by Du and if the appeals court accepts it, does this raise the chance of a remand back to Du reconsideration?

No Remand..The rule is legal issues based on interpretation get a remand..Factual errors get a reversal...

The only thing obvious about the Du trial is she was out to screw Amarin..Fortunately she is too stupid to pull it off..With the AMA and Harvard getting involved..And pointing out..Her little game might have far reaching effects on medical research. Its going to be very hard to sweep this under the rug..The FDA needs to speak up at this point..Castrating the H-W legislation by giving Brand drugs away to generics is not going increase NDA applications at the price FDA has them set at..

And where has the USPTO been hiding out The last couple of months..They must be all Eunuchs..To let some moron judge invalidate seven of their patents and not make squeak about it..I grew up thinking the USPTO was the final authority on patents in the USA...Now I know it is actually know it is an affirmative action female judge who has to rehearse to point up that is the final authority..

Good Lord...

":>)JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News